Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 8, 2016, after the close
10-Q filed Nov 8, 2016, 39 days after period end · 0001171843-16-013023
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $2.50K | $2.50K | $5.00K | $2.50K |
| Net Income | -$5.22M | -$5.64M | -$4.46M | -$6.69M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.59 |
| -$0.06 |
| -$0.05 |
| -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
